Does RISANKIZUMAB-RZAA Cause Drug ineffective? 2,885 Reports in FDA Database
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 2,885 reports of Drug ineffective have been filed in association with RISANKIZUMAB-RZAA. This represents 4.4% of all adverse event reports for RISANKIZUMAB-RZAA.
2,885
Reports of Drug ineffective with RISANKIZUMAB-RZAA
4.4%
of all RISANKIZUMAB-RZAA reports
6
Deaths
379
Hospitalizations
How Dangerous Is Drug ineffective From RISANKIZUMAB-RZAA?
Of the 2,885 reports, 6 (0.2%) resulted in death, 379 (13.1%) required hospitalization, and 3 (0.1%) were considered life-threatening.
Is Drug ineffective Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for RISANKIZUMAB-RZAA. However, 2,885 reports have been filed with the FAERS database.
What Other Side Effects Does RISANKIZUMAB-RZAA Cause?
Psoriasis (6,896)
Pain (2,584)
Fatigue (2,483)
Arthralgia (2,419)
Pruritus (2,311)
Covid-19 (2,145)
Death (1,700)
Fall (1,666)
Surgery (1,662)
Headache (1,554)
What Other Drugs Cause Drug ineffective?
ADALIMUMAB (71,926)
METHOTREXATE (70,142)
ETANERCEPT (60,367)
ADAPALENE (52,181)
ABATACEPT (35,212)
INFLIXIMAB (33,738)
TOCILIZUMAB (32,342)
RITUXIMAB (32,186)
LEFLUNOMIDE (31,396)
HYDROXYCHLOROQUINE (31,057)
Which RISANKIZUMAB-RZAA Alternatives Have Lower Drug ineffective Risk?
RISANKIZUMAB-RZAA vs RISDIPLAM
RISANKIZUMAB-RZAA vs RISEDRONATE
RISANKIZUMAB-RZAA vs RISEDRONIC ACID
RISANKIZUMAB-RZAA vs RISPERDAL
RISANKIZUMAB-RZAA vs RISPERDAL CONSTA